GeneNews completes deal to bring ColonSentry to China
June 30, 2010 by stephenkilmer · Leave a Comment
GeneNews (TSX:GEN) has executed a formal marketing partnership agreement with GeneDiagnostics, a private clinical research and services company in China, to market ColonSentry, the world’s first blood-based test to determine a person’s current risk for colorectal cancer. Under the accord, GeneDiagnostics has obtained non-exclusive rights to market and sell the ColonSentry test in Shanghai and [...]
Listen to BioTuesdays 
